227 related articles for article (PubMed ID: 21955085)
1. Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems.
Vajdy M
Expert Opin Biol Ther; 2011 Nov; 11(11):1501-13. PubMed ID: 21955085
[TBL] [Abstract][Full Text] [Related]
2. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
Chauhan N; Tiwari S; Iype T; Jain U
Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
[TBL] [Abstract][Full Text] [Related]
3. Current adjuvants and new perspectives in vaccine formulation.
Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
[TBL] [Abstract][Full Text] [Related]
4. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
5. The perfect mix: recent progress in adjuvant research.
Guy B
Nat Rev Microbiol; 2007 Jul; 5(7):505-17. PubMed ID: 17558426
[TBL] [Abstract][Full Text] [Related]
6. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
Nordly P; Madsen HB; Nielsen HM; Foged C
Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
[TBL] [Abstract][Full Text] [Related]
7. An overview of adjuvant formulations and delivery systems.
García A; De Sanctis JB
APMIS; 2014 Apr; 122(4):257-67. PubMed ID: 23919674
[TBL] [Abstract][Full Text] [Related]
8. Liposomal vaccine delivery systems.
Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
[TBL] [Abstract][Full Text] [Related]
9. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
Dey AK; Srivastava IK
Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
[TBL] [Abstract][Full Text] [Related]
10. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
[TBL] [Abstract][Full Text] [Related]
11. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
12. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-based vaccine adjuvants - discovery and development.
Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J
Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory biomaterials.
Mallapragada SK; Narasimhan B
Int J Pharm; 2008 Dec; 364(2):265-71. PubMed ID: 18662761
[TBL] [Abstract][Full Text] [Related]
15. Targeting the innate immune response with improved vaccine adjuvants.
Pashine A; Valiante NM; Ulmer JB
Nat Med; 2005 Apr; 11(4 Suppl):S63-8. PubMed ID: 15812492
[TBL] [Abstract][Full Text] [Related]
16. Plant-derived medicines: a novel class of immunological adjuvants.
Licciardi PV; Underwood JR
Int Immunopharmacol; 2011 Mar; 11(3):390-8. PubMed ID: 21056709
[TBL] [Abstract][Full Text] [Related]
17. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
Mrsny RJ
J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
[TBL] [Abstract][Full Text] [Related]
18. Modern subunit vaccines: development, components, and research opportunities.
Moyle PM; Toth I
ChemMedChem; 2013 Mar; 8(3):360-76. PubMed ID: 23316023
[TBL] [Abstract][Full Text] [Related]
19. Adjuvants and delivery systems for viral vaccines--mechanisms and potential.
Jennings R; Simms JR; Heath AW
Dev Biol Stand; 1998; 92():19-28. PubMed ID: 9554256
[TBL] [Abstract][Full Text] [Related]
20. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
